These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
256 related articles for article (PubMed ID: 28522262)
1. Transglutaminase 2 modulation of NF-κB signaling in astrocytes is independent of its ability to mediate astrocytic viability in ischemic injury. Feola J; Barton A; Akbar A; Keillor J; Johnson GVW Brain Res; 2017 Aug; 1668():1-11. PubMed ID: 28522262 [TBL] [Abstract][Full Text] [Related]
3. Phosphorylation of transglutaminase 2 (TG2) at serine-216 has a role in TG2 mediated activation of nuclear factor-kappa B and in the downregulation of PTEN. Wang Y; Ande SR; Mishra S BMC Cancer; 2012 Jul; 12():277. PubMed ID: 22759359 [TBL] [Abstract][Full Text] [Related]
4. Complete transglutaminase 2 ablation results in reduced stroke volumes and astrocytes that exhibit increased survival in response to ischemia. Colak G; Johnson GV Neurobiol Dis; 2012 Mar; 45(3):1042-50. PubMed ID: 22198379 [TBL] [Abstract][Full Text] [Related]
5. Subcellular localization patterns of transglutaminase 2 in astrocytes and neurons are differentially altered by hypoxia. Yunes-Medina L; Feola J; Johnson GVW Neuroreport; 2017 Dec; 28(18):1208-1214. PubMed ID: 28957946 [TBL] [Abstract][Full Text] [Related]
6. Inhibition or ablation of transglutaminase 2 impairs astrocyte migration. Monteagudo A; Ji C; Akbar A; Keillor JW; Johnson GVW Biochem Biophys Res Commun; 2017 Jan; 482(4):942-947. PubMed ID: 27899316 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of HMGB1 reduces rat spinal cord astrocytic swelling and AQP4 expression after oxygen-glucose deprivation and reoxygenation via TLR4 and NF-κB signaling in an IL-6-dependent manner. Sun L; Li M; Ma X; Feng H; Song J; Lv C; He Y J Neuroinflammation; 2017 Nov; 14(1):231. PubMed ID: 29178911 [TBL] [Abstract][Full Text] [Related]
8. Transglutaminase 2 facilitates or ameliorates HIF signaling and ischemic cell death depending on its conformation and localization. Gundemir S; Colak G; Feola J; Blouin R; Johnson GV Biochim Biophys Acta; 2013 Jan; 1833(1):1-10. PubMed ID: 23085038 [TBL] [Abstract][Full Text] [Related]
9. Transglutaminase 2: Friend or foe? The discordant role in neurons and astrocytes. Quinn BR; Yunes-Medina L; Johnson GVW J Neurosci Res; 2018 Jul; 96(7):1150-1158. PubMed ID: 29570839 [TBL] [Abstract][Full Text] [Related]
10. Transglutaminase 2 and NF-κB: an odd couple that shapes breast cancer phenotype. Brown KD Breast Cancer Res Treat; 2013 Jan; 137(2):329-36. PubMed ID: 23224146 [TBL] [Abstract][Full Text] [Related]
11. Transglutaminase 2 suppresses apoptosis by modulating caspase 3 and NF-kappaB activity in hypoxic tumor cells. Jang GY; Jeon JH; Cho SY; Shin DM; Kim CW; Jeong EM; Bae HC; Kim TW; Lee SH; Choi Y; Lee DS; Park SC; Kim IG Oncogene; 2010 Jan; 29(3):356-67. PubMed ID: 19838207 [TBL] [Abstract][Full Text] [Related]
12. Transglutaminase 2 protects against ischemic insult, interacts with HIF1beta, and attenuates HIF1 signaling. Filiano AJ; Bailey CD; Tucholski J; Gundemir S; Johnson GV FASEB J; 2008 Aug; 22(8):2662-75. PubMed ID: 18375543 [TBL] [Abstract][Full Text] [Related]